The Effects of Hypoglycaemia in People With Type 2 Diabetes
NCT02205996 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18
Last updated 2014-08-01
Summary
Strict glycaemic control has been associated with increased hypoglycaemia and mortality rate, the cause of which was unclear, in subjects with type 2 diabetes. In this study, we hypothesised that acute hypoglycaemia will result in platelet activation in people with type 2 diabetes to a higher degree than controls.
Conditions
Interventions
- DRUG
-
Insulin (Humulin S)
Using insulin and glucose infusions (hyperinsulinaemic clamps), blood glucose levels were stabilised over 1 hour to reach 5 mmol/L and maintained at that level for 1 hour, then gradually reduced over 1 hour to 2.8 mmol/L and maintained at that level for 1 hour. Blood samples were collected at times 0 (baseline), 2 hours (euglycaemia), 4 hours (hypoglycaemia) and at 24 hours after the clamp studies.
- DEVICE
-
Euglycaemic Hypoglycaemic Insulin clamp
Sponsors & Collaborators
-
Hull University Teaching Hospitals NHS Trust
collaborator OTHER_GOV -
University of Hull
lead OTHER
Principal Investigators
-
Stephen L Atkin, PhD · Hull York Medical School
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 40 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-11-30
- Primary Completion
- 2013-05-31
- Completion
- 2013-05-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Effects of Modulators of Gluconeogenesis, Glycogenolysis and Glucokinase Activity
NCT05098470 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
GLP-1 and Hypoglycemia
NCT01858896 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Endogenous Glucoseproduction in Patients With Type 2 Diabetes Mellitus During Oral Glucose and iv. Glucose Infusion
NCT02010827 ·Status: COMPLETED
-
Effect of GLP-1 on Microvascular Insulin Responses in Type 1 Diabetes
NCT04133922 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Insulin Secretion in Diabetes Before and After Glycemic Control
NCT00469833 ·Status: COMPLETED ·Phase: NA
-
Metabolic Causes of Thrombosis in Type 2 Diabetes - Question 4
NCT00574340 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Near Normalisation of BG Improves the Potentiating Effect of GLP-1
NCT00612625 ·Status: COMPLETED ·Phase: NA
-
The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men
NCT00256256 ·Status: COMPLETED ·Phase: NA
-
Short-term Effect of Intensive Insulin Therapy on Incretin Secretion
NCT00776243 ·Status: COMPLETED
-
SGLT2 Inhibition and Stimulation of Endogenous Glucose Production: Protocol 2
NCT02592421 ·Status: COMPLETED ·Phase: PHASE3
-
Glucolipotoxicity and Type 2 Diabetes
NCT01375270 ·Status: COMPLETED ·Phase: NA
-
GIP Effects at Insulin Induced Hypoglycemia in Patients With Type 2 Diabetes
NCT01414556 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Dorzagliatin and 1st Phase Insulin and Beta-cell Glucose Sensitivity in IGT and NGT
NCT05468229 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 Diabetes
NCT00993720 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Glucotoxicity and Acute Exercise
NCT01771614 ·Status: WITHDRAWN ·Phase: NA
-
Effect of Empagliflozin Versus Placebo on Brain Insulin Sensitivity in Patients With Prediabetes
NCT03227484 ·Status: COMPLETED ·Phase: PHASE2
-
Quantification of the Incretin Effect in Healthy Subjects and Patients With Type 2 Diabetes
NCT00529048 ·Status: COMPLETED
-
Glucagon-like Peptide-1 in Type 1 Diabetes
NCT04355832 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Pathogenesis of Youth Onset Type 2 Diabetes and Prediabetes
NCT03195400 ·Status: COMPLETED
-
Effect of GLP-1 on Glucose Metabolism in CNS Assessed by PET
NCT01185119 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Insulin and Insulin Pulses During Fasting
NCT06424015 ·Status: RECRUITING ·Phase: NA
-
Monocyte Function and Inflammation in Type 1 Diabetes and Its Modulation
NCT00441844 ·Status: COMPLETED ·Phase: PHASE2
-
Insulin Resistance and Central Nervous System (CNS) Function in Type 2 Diabetes
NCT00212290 ·Status: COMPLETED ·Phase: PHASE4
-
Insulin Deprivation on Brain Structure and Function in Humans With Type 1 Diabetes
NCT03392441 ·Status: COMPLETED ·Phase: NA
-
Albiglutide Glucose Clamp Study in Subjects With Type 2 Diabetes
NCT01475734 ·Status: COMPLETED ·Phase: PHASE2